20,280 resources
By Version
By Realm
Start Prev Rows 8800 - 9000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
hl7.terminology.r4b | R4B | v3-Liquid | Liquid | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | subscription-status-at-event | SubscriptionStatusAtEvent | draft | fhir | 2020-02 | uv | tho | |
hl7.terminology.r4b | R4B | subscription-status-at-event | SubscriptionStatusAtEvent | draft | fhir | 2020-02 | uv | tho | |
hl7.terminology | R5 | v3-IrrigationSolution | IrrigationSolution | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-IrrigationSolution | IrrigationSolution | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-DocumentStorageActive | DocumentStorageActive | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-DocumentStorageActive | DocumentStorageActive | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassFinancialTransaction | ActClassFinancialTransaction | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActClassFinancialTransaction | ActClassFinancialTransaction | active | 2014-03 | uv | tho | ||
hl7.fhir.us.physical-activity | R4 | pa-diagnosticreport-category | PA ServiceRequest Category - USCore | trial-use | 2 | pc | 2024-03 | us | sct |
fhir.nw-gmsa.nhs.uk | R4 | specimen-type | Specimen Type | draft | 2025-04 | us | internal sct | ||
hl7.fhir.us.vrdr | R4 | vrdr-edit-bypass-01-vs | Edit Bypass 01 | active | pher | 2024-10 | us | fhir | |
hl7.fhir.us.vr-common-library | R4 | valueset-edit-bypass-01234-vr | Value Set - Edit Bypass 01234 Vital Records | active | pher | 2025-05 | us | fhir | |
hl7.fhir.us.vrdr | R4 | vrdr-edit-bypass-0124-vs | Edit Bypass 0124 | active | pher | 2024-10 | us | fhir | |
hl7.fhir.us.vrdr | R4 | vrdr-edit-bypass-012-vs | Edit Bypass 012 | active | pher | 2024-10 | us | fhir | |
hl7.terminology | R5 | v2-notAllCodes-0291 | hl7VS-subtypeOfReferencedData | active | 2019-12 | uv | tho | ||
hl7.terminology.r4b | R4B | v2-notAllCodes-0291 | hl7VS-subtypeOfReferencedData | active | 2019-12 | uv | tho | ||
ehelse.fhir.no.grunndata.test | R4 | gd-person-addressprotection.valueset | GdPersonAddressProtectionValueSet | draft | 2020-05 | ||||
hl7.terminology | R5 | v3-RoleClassFlavorAdditive | RoleClassFlavorAdditive | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-RoleClassFlavorAdditive | RoleClassFlavorAdditive | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassPreservative | RoleClassPreservative | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-RoleClassPreservative | RoleClassPreservative | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassColorAdditive | RoleClassColorAdditive | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-RoleClassColorAdditive | RoleClassColorAdditive | active | 2014-03 | uv | tho | ||
fhir.argonaut.r2 | R2 | substance | Argonaut Substance-Reactant for Intolerance and Negation Codes | draft | 2016-10 | us | sct | ||
hl7.terminology | R5 | v3-EntityClassChemicalSubstance | EntityClassChemicalSubstance | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-EntityClassChemicalSubstance | EntityClassChemicalSubstance | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-EntityClassDevice | EntityClassDevice | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-EntityClassDevice | EntityClassDevice | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | sex-parameter-for-clinical-use | Sex Parameter for Clinical Use | active | 1 | pa | 2025-07 | uv | tho |
hl7.terminology.r4b | R4B | sex-parameter-for-clinical-use | Sex Parameter for Clinical Use | active | 1 | pa | 2024-07 | uv | tho |
hl7.terminology | R5 | v3-EmergencyPharmacySupplyType | EmergencyPharmacySupplyType | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-EmergencyPharmacySupplyType | EmergencyPharmacySupplyType | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-RoleClassActiveIngredient | RoleClassActiveIngredient | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-RoleClassActiveIngredient | RoleClassActiveIngredient | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActClassFinancialAdjudication | ActClassFinancialAdjudication | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActClassFinancialAdjudication | ActClassFinancialAdjudication | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActRelationshipMatchesTrigger | ActRelationshipMatchesTrigger | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActRelationshipMatchesTrigger | ActRelationshipMatchesTrigger | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.vhdir | R4 | digitalcertificatetrustframework | VhDir Digital Certificate Trust Framework Value Set | trial-use | 2 | pa | 2018-02 | uv | fhir |
hl7.terminology | R5 | v3-LiquidLiquidEmulsion | LiquidLiquidEmulsion | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-LiquidLiquidEmulsion | LiquidLiquidEmulsion | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xMedicine | x_Medicine | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-xMedicine | x_Medicine | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-xAdministeredSubstance | x_AdministeredSubstance | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-xAdministeredSubstance | x_AdministeredSubstance | active | 2014-03 | uv | tho | ||
hl7.fhir.uv.cpg | R4 | cpg-activity-type-vs | CPG Activity Type Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-pertinence-vs | CPG Case Feature Pertinence Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.fhir.uv.cpg | R4 | cpg-casefeature-type-vs | CPG Case Feature Type Value Set | active | cds | 2024-11 | uv | fhir | |
hl7.terminology | R5 | v3-EntityClassHolder | EntityClassHolder | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-EntityClassHolder | EntityClassHolder | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-QualityMeasureSectionType | QualityMeasureSectionType | active | 2014-03 | uv | loinc | ||
hl7.terminology.r4b | R4B | v3-QualityMeasureSectionType | QualityMeasureSectionType | active | 2014-03 | uv | loinc | ||
ca.on.ppr.r4 | R4 | ProviderRoleAffiliationType-provider | ProviderAffiliationType | draft | |||||
hl7.terminology | R5 | v3-ActClassAccession | ActClassAccession | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActClassAccession | ActClassAccession | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-LocalRemoteControlState | LocalRemoteControlState | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-LocalRemoteControlState | LocalRemoteControlState | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.12199 | LanguageAbilityProficiency | active | 2024-06 | us | tho | ||
hl7.terminology | R5 | v3-LanguageAbilityProficiency | LanguageAbilityProficiency | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-LanguageAbilityProficiency | LanguageAbilityProficiency | active | 2014-03 | uv | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.12249 | LanguageAbilityMode | active | 2024-06 | us | tho | ||
hl7.terminology | R5 | v3-LanguageAbilityMode | LanguageAbilityMode | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-LanguageAbilityMode | LanguageAbilityMode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-DrugEntity | Drug Entity | active | 2022-10 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-DrugEntity | Drug Entity | active | 2022-10 | uv | tho | ||
hl7.terminology | R5 | v3-EntityCode | EntityCode | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-EntityCode | EntityCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-materialForm | materialForm | retired | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-materialForm | materialForm | retired | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-GenderStatus | GenderStatus | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-GenderStatus | GenderStatus | active | 2014-03 | uv | tho | ||
fhir.nigeriaImmunization | R4 | IMMZD16-ValueSet | IMMZD16-ValueSet for AEFI Treatment | draft | 2025-05 | us | internal | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.61 | Care Model | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.19185 | Religious Affiliation | active | 2024-06 | us | tho | ||
hl7.fhir.eu.imaging-manifest-r5 | R5 | periods-of-life-value-set | Periods of Life | draft | 2025-07 | eu | sct | ||
hl7.fhir.eu.imaging-r5 | R5 | periods-of-life-value-set | Periods of Life | draft | 2025-07 | eu | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.7.1 | SupportedFileFormats | active | 2024-06 | us | tho | ||
hl7.fhir.us.spl | R5 | valueset-AllNDCProducts | All NDC Products | trial-use | 1 | brr | 2025-07 | us | ndc |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.1 | Pregnancy Status | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.10 | Pap Smear Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.11 | HIV Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.12 | Human Papilloma Virus Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.13 | Chlamydia Trachomatis Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.14 | Neisseria Gonorrhoeae Tests | active | 2023-07 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.17 | Contraceptive Type | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.209 | Yes and No Answers | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.210 | Pap Smear Results | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.211 | Contraceptive discussion | active | 2023-08 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.29 | Insurance Coverage Type | active | 2023-07 | us | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.3 | Organism Detection | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.31 | English Proficiency | active | 2023-07 | us | sct | ||
hl7.fhir.us.vitals | R4 | LowOnlyNumericResultIntVS | Low Only Numeric Result Interpretation value set | draft | 2024-10 | us | tho | ||
nhsd.assets.stu3 | R3 | ValueSet-PEC-ExemptionType-1 | PEC Exemption Type | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ValueSet-PersonRelationshipType-1 | Person Relationship Type | draft | 2017-10 | ||||
nhsd.assets.stu3 | R3 | ITK-PatientAllergyChangeType-1 | Patient Allergy Change Type | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ITK-PatientMedicationChangeType-1 | Patient Medication Change Type | draft | 2017-09 | ||||
nhsd.assets.stu3 | R3 | ITK-ConditionFlag-1 | ITK Condition Flag | draft | 2018-04 | ||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-AdditionalRequirementType-1 | eRS Additional Requirement Type | draft | |||||
nhsd.assets.stu3 | R3 | ITK-RecipientType-1 | ITK Recipient Type | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | ITK-BusAcknowledgement-1 | ITK Business Acknowledgement | draft | 2017-09 | ||||
nhsd.assets.stu3 | R3 | ITK-InfAcknowledgement-1 | ITK Infrastructure Acknowledgement | draft | 2017-12 | ||||
nhsd.assets.stu3 | R3 | ITK-ResponseCodes-1 | ITK Response Codes | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | eRS-BookableType-1 | eRS Bookable Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ClinicType-1 | eRS Clinic Type | draft | |||||
uk.nhsdigital.r4.test | R4 | d2a51dd0-9e86-4cea-9064-077637cb79b7 | ERSAppointmentCancellationReason | draft | |||||
uk.nhsdigital.r4.test | R4 | d2a51dd0-9e86-4cea-9064-077637cb79b7 | ERSReferralState | draft | |||||
uk.nhsdigital.r4.test | R4 | bb928767-263e-457c-9ee0-1a3d239ddc10 | ERSClinicType | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CommissioningProvisioning-1 | eRS Commissioning Provisioning | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CommissioningType-1 | eRS Commissioning Type | draft | |||||
nhsd.assets.stu3 | R3 | ITK-MessageEvent-2 | ITK Message Event | active | 2018-08 | ||||
nhsd.assets.stu3 | R3 | eRS-GenderTreated-1 | eRS Gender Treated | draft | |||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-OrganisationType-1 | eRS Organisation Type | draft | |||||
NHSDigital.FHIR.STU3 | R3 | eRS-ReferralCancellationReason-1 | eRS Referral Cancellation Reason | active | 2022-03 | ||||
nhsd.assets.stu3 | R3 | eRS-ReferralTreatmentMissingReason-1 | eRS Referral Treatment Missing Reason | draft | |||||
nhsd.assets.stu3 | R3 | eRS-RequestFlowType-1 | eRS Request Flow Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-FetchOutcomeType-1 | DO NOT USE - eRS Fetch Outcome Type | retired | |||||
nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Referral Type | active | |||||
nhsd.assets.stu3 | R3 | eRS-Specialty-1 | eRS Specialty | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ReferralRequestStatus-1 | eRS Referral Request Status | draft | |||||
nhsd.assets.stu3 | R3 | ValueSet-eRS-AppointmentType-1 | eRS Appointment Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CapacityAlert-1 | eRS Capacity Alert | draft | |||||
nhsd.assets.stu3 | R3 | eRS-CapacityStatus-1 | eRS Capacity Status | draft | |||||
nhsd.assets.stu3 | R3 | eRS-RequestType-1 | eRS Request Type | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ServiceSearch-SortBy-1 | eRS ServiceSearch Sort By - DO NOT USE | retired | |||||
nhsd.assets.stu3 | R3 | eRS-SortBy-1 | eRS Sort By | draft | |||||
nhsd.assets.stu3 | R3 | eRS-IWT-1 | eRS Indicative Wait Time | draft | |||||
nhsd.assets.stu3 | R3 | eRS-ReferralLetterIntention-1 | eRS Referral Letter Intention | draft | |||||
hl7.terminology | R5 | v3-ParticipationAuthenticator | ParticipationAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ParticipationAuthenticator | ParticipationAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ParticipationLegalAuthenticator | ParticipationLegalAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ParticipationLegalAuthenticator | ParticipationLegalAuthenticator | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-SwabDrugForm | SwabDrugForm | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-SwabDrugForm | SwabDrugForm | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-PersonalAndLegalRelationshipRoleType | PersonalAndLegalRelationshipRoleType | active | 2023-06 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-PersonalAndLegalRelationshipRoleType | PersonalAndLegalRelationshipRoleType | active | 2023-06 | uv | tho | ||
de.basisprofil.r4 | R4 | valueset-wg14 | WG14 ValueSet | active | 2025-06 | ||||
HIE2.packages | R4 | results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS | active | 2022-01 | uv | sct | ||
hl7.fhir.us.registry-protocols | R4 | LesionComplexity | Complexity of the Lesion | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.registry-protocols | R4 | CABGIndication | CABG Indication | active | cic | 2023-11 | us | fhir | |
hl7.fhir.us.breast-radiology | R4 | rde1562-laterality-from-landmark | RDE1562 Laterality from landmark | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1565-type | RDE1565 Type | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1568-distribution | RDE1568 Distribution | draft | 2022-12 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1571-associated-features | RDE1571 Associated features | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1576-shape | RDE1576 Shape | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1577-type | RDE1577 Type | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1578-density | RDE1578 Density | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1579-margin | RDE1579 Margin | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1580-orientation | RDE1580 Orientation | draft | 2022-10 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1586-assessment-category | RDE1586 Assessment category | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1587-breast-composition-category | RDE1587 Breast composition category | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1588-breast-laterality | RDE1588 Breast laterality | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1589-implant-presence | RDE1589 Implant presence | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1590-prior-mastectomy | RDE1590 Prior mastectomy | draft | 2022-11 | us | fhir | ||
hl7.fhir.us.breast-radiology | R4 | rde1602-type | RDE1602 Type | draft | 2022-12 | us | fhir | ||
hl7.fhir.it.lab-report | R4 | aifa-aic | AIFA AIC | active | 2024-03 | it | internal | ||
hl7.fhir.it.terminology | R4 | aifa-ge | AIFA Gruppo di Equivalenza | active | 2025-06 | it | internal | ||
hl7.org.nz.fhir.ig.formulary | R4B | atc-code | ATC codes | active | 2025-07 | nz | atc | ||
nictiz.fhir.nl.r4.zib2020 | R4 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.5.4--20200901000000 | AanduidingBijNummerCodelijst | active | nl | oid | |||
hl7.terminology | R5 | verificationresult-can-push-updates | Can-push-updates | active | pa | 2024-04 | uv | tho | |
hl7.terminology.r4b | R4B | verificationresult-can-push-updates | Can-push-updates | active | pa | 2024-04 | uv | tho | |
ca.on.oh-olis | R4 | olis-InterpretationProvider | Interpretation | active | tho | ||||
hl7.fhir.us.breast-radiology | R4 | rde1556-presence | RDE1556 Presence | draft | 2022-12 | us | fhir | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.34 | AbnormalityOfGaitAndMobility | active | 2021-07 | us | icd | ||
HIE2.packages | R4 | absent-or-unknown-allergies-uv-ips | Absent or Unknown Allergies - IPS | active | 2022-01 | uv | fhir | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.61--20180127221947 | Absent or Unknown Devices | draft | 2024-08 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-devices-uv-ips | Absent or Unknown Devices - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-immunizations-uv-ips | Absent or Unknown Immunization - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-medications-uv-ips | Absent or Unknown Medication - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-problems-uv-ips | Absent or Unknown Problems - IPS | active | 2022-01 | uv | fhir | ||
HIE2.packages | R4 | absent-or-unknown-procedures-uv-ips | Absent or Unknown Procedures - IPS | active | 2022-01 | uv | fhir | ||
hl7.fhir.us.mcode | R4 | mcode-tumor-size-units-vs | Tumor Size Units Value Set | active | 3 | cic | 2025-02 | us | ucum |
hl7.terminology | R5 | cql-access-modifier | CQL Access Modifier | draft | cds | 2024-02 | uv | tho | |
hl7.terminology.r4b | R4B | cql-access-modifier | CQL Access Modifier | draft | cds | 2024-02 | uv | tho | |
hl7.terminology | R5 | v3-ActEncounterAccommodationCode | ActEncounterAccommodationCode | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActEncounterAccommodationCode | ActEncounterAccommodationCode | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AcknowledgementCondition | AcknowledgementCondition | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-AcknowledgementCondition | AcknowledgementCondition | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-AcknowledgementType | AcknowledgementType | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-AcknowledgementType | AcknowledgementType | active | 2014-03 | uv | tho | ||
ee.hl7.fhir.base.r5 | R5 | ee-act-priority | Act Priority | draft | 2023-08 | ee | tho | ||
ee.fhir.terminology | R5 | act-priority | Act Priority | active | 2025-06 | ee | tho | ||
hl7.terminology | R5 | v3-ActConsentDirectiveType | ActConsentDirectiveType | active | sec | 2019-03 | uv | tho | |
hl7.terminology.r4b | R4B | v3-ActConsentDirectiveType | ActConsentDirectiveType | active | sec | 2019-03 | uv | tho | |
hl7.terminology | R5 | v3-ActConsentDirective | ActConsentDirective | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActConsentDirective | ActConsentDirective | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActPrivacyLaw | ActPrivacyLaw | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActPrivacyLaw | ActPrivacyLaw | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActPrivacyPolicy | ActPrivacyPolicy | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActPrivacyPolicy | ActPrivacyPolicy | active | 2014-03 | uv | tho | ||
hl7.terminology | R5 | v3-ActInformationSensitivityPolicy | ActInformationSensitivityPolicy | active | 2014-03 | uv | tho | ||
hl7.terminology.r4b | R4B | v3-ActInformationSensitivityPolicy | ActInformationSensitivityPolicy | active | 2014-03 | uv | tho | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.22--20170502000000 | ActStatusActiveCompletedAbortedCancelled | draft | 2024-08 | uv | tho | ||
hl7.cda.uv.ips | R4 | 2.16.840.1.113883.11.22.12--20170330000000 | ActStatusActiveCompletedAbortedSuspended | draft | 2024-08 | uv | tho | ||
ch.fhir.ig.ch-term | R4 | ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | active | 2025-05 | ch | tho | ||
signal.core.r4 | R4 | questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 1 | pa | us | ||
hl7.terminology | R5 | adverse-event-clinical-research-seriousness-criteria | Adverse Event Clinical Research Seriousness Criteria | active | 1 | brr | 2023-07 | uv | ncit |